Intercept Pharmaceuticals Inc. is a prominent biopharmaceutical company that focuses on developing and commercializing innovative treatments for liver diseases. With a strong portfolio of products, including the FDA-approved Ocaliva, Intercept is dedicated to improving the lives of patients suffering from chronic liver conditions.
Notification